ARCHITECT ANTI-HBC II
Report
- Report Number
- 2623532-2011-00001
- Event Type
- Malfunction
- Date Received
- January 6, 2011
- Report Date
- December 20, 2010
- Manufacturer
- ABBOTT DIAGNOSTICS INT'L, LTD
- Product Code
- LOM
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- GR
- Reporter Occupation
- OTHER
Narratives
(B)(4). FURTHER INVESTIGATION OF THE CUSTOMER ISSUE INCLUDED A REVIEW OF THE COMPLAINT TEXT, TESTING OF FILE KITS, A SEARCH FOR SIMILAR COMPLAINTS, AND A REVIEW OF LABELING. RETAINED KITS OF ARCHITECT ANTI-HBC II REAGENT LOTS 92332HN00 AND 93464HN00 WERE CALIBRATED AND MET SPECIFICATIONS. ALL CONTROL VALUES MET SPECIFICATIONS AND WERE WITHIN RANGE. IN ADDITION, CLINICAL SENSITIVITY WAS EVALUATED FOR BOTH REAGENT LOTS WITH ACCEPTABLE RESULTS. TRACKING AND TRENDING DID NOT IDENTIFY ANY ADVERSE TREND RELATED TO THE CUSTOMER ISSUE. LABELING WAS REVIEWED AND FOUND TO BE ADEQUATE. BASED ON THE EVALUATION NO PRODUCT DEFICIENCY FOR FALSE (B)(6) ARCHITECT (B)(4) RESULTS WAS IDENTIFIED.
(B)(4). THIS REPORT IS BEING FILED ON AN INTERNATIONAL PRODUCT, ARCHITECT ANTI-HBC II, LIST 8L44-25, THAT HAS A SIMILAR US PRODUCT DISTRIBUTED IN THE US, ARCHITECT CORE, LIST 6L22.A FOLLOW-UP REPORT WILL BE SUBMITTED WHEN THE INVESTIGATION IS COMPLETE.
THE CUSTOMER STATED AN ARCHITECT I1000SR ANALYZER GENERATED A FALSE NEGATIVE ANTI-HBC II RESULT FOR ONE PATIENT KNOWN TO BE POSITIVE BASED ON TESTING PERFORMED ON AN AXSYM ANALYZER AND SUPPORTING TEST RESULTS. THERE WAS NO ADVERSE IMPACT TO PATIENT MANAGEMENT REPORTED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | ARCHITECT ANTI-HBC II | IN VITRO DIAGNOSTIC TEST FOR THE DETECTION OF HEPATITIS B CORE ANTIBODIES | LOM | ABBOTT DIAGNOSTICS INT'L, LTD | 93464HN00 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | ARCH I1000SR LN 1L86-01 SN (B)(4)| ARCH I1000SR LN 1L86-01 SN (B)(4) |